Pre-trained quantum convolutional neural network for COVID-19 disease classification using computed tomography images

基于计算机断层扫描图像的预训练量子卷积神经网络用于COVID-19疾病分类

阅读:1

Abstract

BACKGROUND: The COVID-19 pandemic has had a significant influence on economies and healthcare systems around the globe. One of the most important strategies that has proven to be effective in limiting the disease and reducing its rapid spread is early detection and quick isolation of infections. Several diagnostic tools are currently being used for COVID-19 detection using computed tomography (CT) scan and chest X-ray (CXR) images. METHODS: In this study, a novel deep learning-based model is proposed for rapid detection of COVID-19 using CT-scan images. The model, called pre-trained quantum convolutional neural network (QCNN), seamlessly combines the strength of quantum computing with the feature extraction capabilities of a pre-trained convolutional neural network (CNN), particularly VGG16. By combining the robust feature learning of classical models with the complex data handling of quantum computing, the combination of QCNN and the pre-trained VGG16 model improves the accuracy of feature extraction and classification, which is the significance of the proposed model compared to classical and quantum-based models in previous works. RESULTS: The QCNN model was tested on a SARS-CoV-2 CT dataset, initially without any pre-trained models and then with a variety of pre-trained models, such as ResNet50, ResNet18, VGG16, VGG19, and EfficientNetV2L. The results showed the VGG16 model performs the best. The proposed model achieved 96.78% accuracy, 0.9837 precision, 0.9528 recall, 0.9835 specificity, 0.9678 F1-Score and 0.1373 loss. CONCLUSION: Our study presents pre-trained QCNN models as a viable technique for COVID-19 disease detection, showcasing their effectiveness in reaching higher accuracy and specificity. The current paper adds to the continuous efforts to utilize artificial intelligence to aid healthcare professionals in the diagnosis of COVID-19 patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。